HealthStream, Inc. (HSTM) fair value analysis
Nasdaq · Updated 2026-10-19
HSTM price how computed
Forward Fair Value verdict
UndervaluedHSTM is trading at a 10–25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $33.13
- Sector
- Healthcare
- 12-month range
- $19.88–$33.75
- Market cap
- $1.01B
- From 52-week high
- -1.8%
- Shares outstanding
- 30.6M
- Rank in Healthcare by discount to fair value
- #31 of 108
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
HealthStream, Inc. is a healthcare company that provides learning and training solutions, workforce management services, and other software platforms designed for healthcare organizations. The company operates in the United States and serves hospitals, health systems, and other healthcare providers.
HSTM currently ranks #31 of 108 Healthcare stocks by discount to fair value. It has screened as Undervalued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $1.01B
- P/E (trailing)
- 41x
- Revenue (TTM)
- $321M
- Net margin
- 6.6%
- EPS (TTM)
- $0.81
- Gross margin
- 65.3%
- Debt / equity
- 0.04
- Revenue growth (3-yr avg)
- 6.3%
- Shares outstanding
- 30.6M
Derived indicators how computed
- Quality grade
- B
- Margin trend
- Stable
- 52-week position
- The top quarter of its range
- DCF cross-check
- Fairly Valued
Technicals how computed
- RSI (14-day)
- 75 · overbought
- 50-day average
- $29.85
- 200-day average
- $25.00
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
- Momentum score
- 82 · grade B
- Positive weeks (of 12)
- 3
Dividends how computed
- Paid, last 12 months
- $0.14 per share (4 payments)
- Yield on last price
- 0.41%
- Consecutive years of increases
- 2
- Last ex-dividend date
- 2026-08-17
- Last payment date
- 2026-08-28
Earnings how computed
- Next earnings report
- 2026-11-02
- Last 8 quarters vs consensus
- 7 beat, 1 missed
- Quarter by quarter
- 2026-06 ▲ beat (+35.3%)
2026-03 ▲ beat (+17.6%)
2025-12 ▲ beat (+38.5%)
2025-09 ▲ beat (+11.1%)
2025-06 ▲ beat (+5.9%)
2025-03 ▼ miss (-17.6%)
2024-12 ▲ beat (+11.7%)
2024-09 ▲ beat (+58.3%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 2 buy · 3 hold · 0 sell (5 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $35
- Target vs last price
- +5.6%
What our data shows for HSTM
- Our model validated 17 trailing price-to-earnings windows for HSTM, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $19.88–$33.75.
- The 14-day relative strength index sits at an overbought 75.
- 3 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for HSTM
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent HSTM news
TickrTrends' derived news-sentiment signal for HSTM is currently leaning positive, computed from recent coverage.
- HSTM Initiates Coverage On HealthStream -- Rating Set to Hold (gurufocus.com, 2026-10-14)
TickrTrends take: HSTM recently entered coverage with a Hold rating, a positioning that aligns with TickrTrends' current Undervalued assessment of the stock. For valuation-focused investors, this neutral stance from new coverage provides a baseline context against which to monitor whether fundamentals shift enough to warrant an upgraded rating in the Healthcare sector. The divergence between the Hold rating and the Undervalued valuation signal suggests the market may not yet be pricing in potential value that a detailed fundamental reassessment could reveal.
What people are saying
Follow the HSTM conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — TickrTrends' derived indicators for HSTM in the Healthcare sector showed several positive shifts this week. Momentum improved from none to B, while the quality grade rose from D to B, and the RSI zone moved into overbought territory. The stock's sector discount rank slipped slightly from 39 to 44, though the current valuation verdict remains undervalued.
- 2026-10-05 — Healthcare Technologies (HSTM) has moved lower in the Healthcare sector's discount rankings this week, declining from position 32 to position 39 based on TickrTrends' derived indicators. Despite this shift in relative valuation positioning, HSTM maintains an undervalued assessment according to current analysis metrics.
- 2026-09-28 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is HSTM stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), HSTM is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is HSTM's TickrTrends verdict?
HSTM's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does HSTM compare to other Healthcare stocks?
HSTM ranks #31 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is HSTM overbought or oversold?
HSTM's 14-day RSI is in the overbought zone on TickrTrends' latest weekly data.
Does HSTM pay a dividend?
Yes. HSTM paid $0.14 per share over the last twelve months (4 payments), a 0.41% yield on TickrTrends' last price, and has raised the annual total for 2 consecutive years. The last ex-dividend date was 2026-08-17.
When does HSTM report earnings next?
HSTM's next earnings report is scheduled for 2026-11-02, per the published earnings calendar.
Does HSTM usually beat earnings estimates?
Over its last 8 reported quarters HSTM beat the consensus estimate 7 times and missed 1 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about HSTM?
Of 5 analysts covering HSTM, 2 rate it a buy, 3 a hold and 0 a sell - hold-leaning, with a consensus price target of $35 (+5.6% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Healthcare
Head-to-head comparisons
HSTM vs AMPH · HSTM vs BTSG · HSTM vs CI · HSTM vs DVA · HSTM vs ETON